Gemcitabine/Nab-Paclitaxel versus Gemcitabine/Carboplatin for Advanced Urothelial Carcinoma.

Xin AnCong XueMeiting ChenMengqian NiHuali MaLi TianRiqing HuangXiangdong LiYun-Lin YeTao QinPei DongFangjian ZhouJing PengKai YaoFangjian ZhouZhuo-Wei LiuYanxia Shi

Published in: BJU international (2023)

While not powered for comparison, first-line GA showed similar efficacy and better tolerability with GA, and might be considered a rational alternative to GCb.

Keyphrases

pet ct
locally advanced
phase ii study
open label
advanced non small cell lung cancer
phase iii
radiation therapy
randomized controlled trial
clinical trial
double blind
epidermal growth factor receptor